LONDON--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...

Users can go to dexcom.com/theft-check for information on how to determine if sensors are from the affected lots and what ...

Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The Food and Drug Administration cleared Dexcom’s Stelo Glucose Biosensor ...

After months of international availability, the Dexcom G7 constant glucose monitor received its FDA clearance to distribute in the US. Ahead of the wide rollout, we got to go hands-on with a demo ...

Along with the glucose health educational component, the National Glucose Awareness Week initiative also includes efforts to increase awareness of the biosensors available to help track real-time ...

The G7 system is now available in the U.K., Ireland, Germany, Austria and Hong Kong. Dexcom said it plans to reach outlets in South Africa and New Zealand in the weeks ahead and additional countries ...

On the other hand, DexCom is a pure-play CGM company whose target market consists mainly of people with Type 1 and Type 2 ...

Add Yahoo as a preferred source to see more of our stories on Google. The Dexcom G7 Continuous Glucose Monitoring (CGM) System, shown here with an iPhone and an Apple Watch. Dexcom warned patients ...

DexCom (DXCM) faces GLP-1 disruption as it targets non-insulin Type 2 CGM growth. Read here for a detailed invesment analysis ...

Add Yahoo as a preferred source to see more of our stories on Google. June 11 (Reuters) - Drug wholesaler Pharmsource LLC said it was unaware the Dexcom glucose ‌sensors it bought from licensed ...

Compare Apple Watch CGM apps for blood sugar readings, including Dexcom G7, FreeStyle Libre, and Eversense watch support.